Eagle Asset Management Inc Global Blood Therapeutics, Inc. Transaction History

Eagle Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$52.76 - $74.49 $1.71 Million - $2.42 Million	-32,426 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$48.73 - $81.82 $20.2 Million - $33.9 Million	-414,102 Reduced 92.74%	32,426 $2.16 Million
Q1 2020 May 11, 2020	BUY	$41.72 - $87.2 $116,941 - $244,421	2,803 Added 0.63%	446,528 $22.8 Million
Q4 2019 Feb 07, 2020	SELL	$45.7 - $81.86 $104,470 - $187,131	-2,286 Reduced 0.51%	443,725 $35.3 Million
Q3 2019 Nov 04, 2019	BUY	$45.35 - $57.91 $410,417 - $524,085	9,050 Added 2.07%	446,011 $21.6 Million
Q2 2019 Aug 05, 2019	BUY	$52.6 - $63.29 $23 Million - $27.7 Million	436,961 New	436,961 $23 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.